Pharmacogenomic tests of oncology drugs at Instituto Nacional de Câncer (INCA)
The implementation, current status and future perspectives of the pharmacogenetics/genomics (PGx) testing program developed at Instituto Nacional de Cancer (INCA) are presented. Initial selection of drug-gene pairs for PGx testing was based on clinically-validated PGx associations and availability o...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações Ltda.
2021-10-01
|
| Series: | Brazilian Journal of Oncology |
| Subjects: | |
| Online Access: | http://www.brazilianjournalofoncology.com.br/details/152/en-US/pharmacogenomic-tests-of-oncology-drugs-at-instituto-nacional-de-cancer--inca- |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|